Inventor · disambiguated record
Ronald James Hause, Jr.
Also filed as: HAUSE JR RONALD JAMES · HAUSE RONALD
3 granted patents·17 pending applications·1 citations·filing 2018–2025
49Inventor score
Files withJUNO THERAPEUTICS INC9SHAPE THERAPEUTICS INC6CELGENE CORP2ABVITRO LLC1BANJANIN BORA SRECKO1
Top patents by PatentIndex Score
20 records- 0176US2025123281A1Uses of anti-bcma chimeric antigen receptorsCELGENE CORP·Filed 2024·Application pending·0 cites
- 0275US12161670B2Phenotypic markers for cell therapy and related methodsJUNO THERAPEUTICS INC·Filed 2018·Granted Dec 10, 2024·1 cites·20 claims
- 0369US2025059253A1Phenotypic markers for cell therapy and related methodsJUNO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0465US2024158837A1Epigenetic analysis of cell therapy and related methodsJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0560US2021128619A1Uses of anti-bcma chimeric antigen receptorsCELGENE CORP·Filed 2020·Application pending·0 cites
- 0660US2025022532A1Regulating enhancer activity using machine-learningSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0758US2025342903A1Methods and systems for transformer-based biological sequence modelsSHAPE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0858US2025026795A1Functional aav capsids for intravitreal administrationSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0957US2023317206A1Methods and compositions for the molecular diagnosis of microsatellite instability and treatments for cancerUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 1057US2025205363A1Functional aav capsids for systemic administrationSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1155US2025356949A1Machine-learning based design of engineered guide systems for adenosine deaminase acting on rna editingSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1254US11821027B2Epigenetic analysis of cell therapy and related methodsJUNO THERAPEUTICS INC·Filed 2018·Granted Nov 21, 2023·0 cites·29 claims
- 1351US2023178239A1Methods of identifying features associated with clinical response and uses thereofJUNO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1449US2022412954A1Methods of determining attributes of therapeutic t cell compositionsJUNO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1546US2025014676A1Generative sequence screening with conditional gans, diffusion models, and denoising diffusion conditional gansSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1645US2022225597A1Mouse model for assessing toxicities associated with immunotherapiesJUNO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1743US12049667B2High-throughput polynucleotide library sequencing and transcriptome analysisABVITRO LLC·Filed 2018·Granted Jul 30, 2024·0 cites·33 claims
- 1841US2025364080A1Structural and transformer based machine-learning models for design of engineered guide systems for adenosine deaminase acting on rna editingBANJANIN BORA SRECKO·Filed 2023·Application pending·0 cites
- 1938US2020292526A1Methods of identifying cellular attributes related to outcomes associated with cell therapyJUNO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2033US2020078404A1Combination of a cell therapy and an immunomodulatory compoundJUNO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →